J Korean Assoc Oral Maxillofac Surg.  2016 Oct;42(5):307-314. 10.5125/jkaoms.2016.42.5.307.

Retiform hemangioendothelioma in the infratemporal fossa and buccal area: a case report and literature review

Affiliations
  • 1Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine, Incheon, Korea. kik@inha.ac.kr
  • 2Department of Oral and Maxillofacial Surgery, Catholic Kwandong University International St. Mary's Hospital, Incheon, Korea.

Abstract

We report a case of retiform hemangioendothelioma (RH) located in the infratemporal fossa and buccal area in a 13-year-old Korean boy. The tumor originated from the sphenoid bone of the infratemporal fossa area and spread into the cavernous sinus, orbital apex, and retro-nasal area with bone destruction of the pterygoid process. Tumor resection was conducted via Le Fort I osteotomy and partial maxillectomy to approach the infratemporal fossa and retro-nasal area. The diagnosis of RH was confirmed after surgery. In the presented patient, surgical excision was incomplete, and close follow-up was performed. There was no evidence of expansion or metastasis of the residual tumor in the 8 years after surgery. In cases of residual RH with low likelihood of expansion and metastasis, even though RH is an intermediate malignancy, close follow-up can be the appropriate treatment choice over additional aggressive therapy. To date, 29 papers and 48 RH cases have been reported, including this case. This case is the second reported RH case presenting as primary bone tumor and the first case originating in the oromaxillofacial area.

Keyword

Retiform hemangioendothelioma; Infratemporal fossa; Le Fort osteotomy; Residual neoplasm

MeSH Terms

Adolescent
Cavernous Sinus
Diagnosis
Follow-Up Studies
Hemangioendothelioma*
Humans
Male
Neoplasm Metastasis
Neoplasm, Residual
Orbit
Osteotomy
Osteotomy, Le Fort
Sphenoid Bone

Figure

  • Fig. 1 Preoperative clinical photograph. A. Extraoral image of buccal cheek swelling. B. Intraoral image of buccal cheek swelling.

  • Fig. 2 Preoperation magnetic resonance imaging. A. Axial T2-weighted image of low signal intensity in posterior maxillar and retro-nasal area with bony destruction of pterygoid process (black and white arrows). B. Axial T2-weighted image of homogeneous low signal intensity in buccal area. C. Coronal T2-weighted image of heterogeneous low signal intensity in retro-nasal cavity, infratemporal fossa, and cavernous sinus through foramen rotundum (arrows). D. Sagittal T1-weighted image of homogeneous low signal intensity in infratemporal fossa, and orbital apex through infraorbital fissure (arrows).

  • Fig. 3 Intraoperative photograph. A. Le Fort I osteotomy reveals buccal, infratemporal fossa, maxillary sinus and nasal cavity. B. Main mass of buccal, infratemporal and retro-nasal area. C. Segmentally resected masses of inferior orbital fissure area.

  • Fig. 4 Microscopic findings of retiform hemangioendothelioma. A. Characteristic elongated and narrow arborizing vascular channels and focal lymphocytic infiltrate (H&E staining, ×40). B. Monomorphic endothelial cells with hobnail appearance simulate the architecture of rete testis (H&E staining, ×200). C. Vacuolated cells and focal papillae with hyaline core (H&E staining, ×200). D. Neoplastic cells are immunohistochemically reactive for vascular marker, CD31 (immunohistochemistry staining, ×200).

  • Fig. 5 Seven-month (A, B) and four-year (C, D) follow-up magnetic resonance imaging demonstrating residual tumor segments on infratemporal fossa area with no significant interval changes. A, C. Aixial T2-weighted images of low signal intensity in infratemporal fossa area and inferior orbital fissure (black and white arrows). B, D. Coronal T2-weighted images of low signal intensity in cavernous sinus and pterygoid plate (black and white arrows).


Reference

1. Calonje E, Fletcher CD, Wilson-Jones E, Rosai J. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol. 1994; 18:115–125. PMID: 8291650.
2. Fukunaga M, Endo Y, Masui F, Yoshikawa T, Ishikawa E, Ushigome S. Retiform haemangioendothelioma. Virchows Arch. 1996; 428:301–304. PMID: 8764941.
Article
3. Aditya GS, Santosh V, Yasha TC, Shankar SK. Epithelioid and retiform hemangioendothelioma of the skull bone--report of four cases. Indian J Pathol Microbiol. 2003; 46:645–649. PMID: 15025366.
4. El Darouti M, Marzouk SA, Sobhi RM, Bassiouni DA. Retiform hemangioendothelioma. Int J Dermatol. 2000; 39:365–368. PMID: 10849129.
Article
5. Tan D, Kraybill W, Cheney RT, Khoury T. Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol. 2005; 32:634–637. PMID: 16176302.
Article
6. Serel S, Serel BI, Uluc A, Heper AO, Gultan MS. Congenital retiform hemangioendothelioma. Indian J Dermatol. 2007; 52:160–162.
Article
7. O'Duffy F, Timon C, Toner M. A rare angiosarcoma: retiform haemangioendothelioma. J Laryngol Otol. 2012; 126:200–202. PMID: 21888747.
8. Albertini AF, Brousse N, Bodemer C, Calonje E, Fraitag S. Retiform hemangioendothelioma developed on the site of an earlier cystic lymphangioma in a six-year-old girl. Am J Dermatopathol. 2011; 33:e84–e87. PMID: 21915027.
Article
9. Zhang G, Lu Q, Yin H, Wen H, Su Y, Li D, et al. A case of retiform-hemangioendothelioma with unusual presentation and aggressive clinical features. Int J Clin Exp Pathol. 2010; 3:528–533. PMID: 20606734.
10. Hirsh AZ, Yan W, Wei L, Wernicke AG, Parashar B. Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature. Sarcoma. 2010; DOI: 10.1155/2010/756246.
Article
11. Duke D, Dvorak A, Harris TJ, Cohen LM. Multiple retiform hemangioendotheliomas. A low-grade angiosarcoma. Am J Dermatopathol. 1996; 18:606–610. PMID: 8989934.
12. Dufau JP, Pierre C, De Saint Maur PP, Bellavoir A, Gros P. Retiform hemangioendothelioma. Ann Pathol. 1997; 17:47–51. PMID: 9162159.
13. Mentzel T, Stengel B, Katenkamp D. Retiform hemangioendothelioma. Clinico-pathologic case report and discussion of the group of low malignancy vascular tumors. Pathologe. 1997; 18:390–394. PMID: 9432675.
14. Sanz-Trelles A, Rodrigo-Fernandez I, Ayala-Carbonero A, Contreras-Rubio F. Retiform hemangioendothelioma. A new case in a child with diffuse endovascular papillary endothelial proliferation. J Cutan Pathol. 1997; 24:440–444. PMID: 9274963.
Article
15. Schommer M, Herbst RA, Brodersen JP, Kiehl P, Katenkamp D, Kapp A, et al. Retiform hemangioendothelioma: another tumor associated with human herpesvirus type 8? J Am Acad Dermatol. 2000; 42:290–292. PMID: 10642690.
Article
16. Ulrich D, Hrynyschyn K. Fast growing multifocal retiform hemangioendothelioma: a case report. Eur J Plast Surg. 2002; 25:47–49.
17. Coutinho MLF. Laser indications hemangiomas in children. An Acad Nac Med. 2002; 162:74–76.
18. Escudero AG, Sanchez JS, Bustos GN, Serrano TG, Martin JJR, Campora RG. Retiform hemangioendothelioma: a report of two cases and literature review. Acta Dermosifiliogr. 2003; 94:102–106.
19. Botros MF, Abdo I, Foda S, Amer H, Attia N, Saad S, et al. Retiform hemangioendothelioma. Egypt Dermatol Online J. 2005; 1:1–4.
20. Ioannidou D, Panayiotides J, Krasagakis K, Stefanidou M, Manios A, Tosca A. Retiform hemangioendothelioma presenting as bruiselike plaque in an adult woman. Int J Dermatol. 2006; 45:53–55. PMID: 16426378.
Article
21. Parsons A, Sheehan DJ, Sangueza OP. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3. Am J Dermatopathol. 2008; 30:31–33. PMID: 18212541.
Article
22. Love WE, Keiler SA, Tamburro JE, Honda K, Gosain AK, Bordeaux JS. Surgical management of congenital dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2009; 61:1014–1023. PMID: 19925926.
Article
23. Bhutoria B, Konar A, Chakrabarti S, Das S. Retiform hemangioendothelioma with lymph node metastasis: a rare entity. Indian J Dermatol Venereol Leprol. 2009; 75:60–62. PMID: 19172034.
Article
24. Emberger M, Laimer M, Steiner H, Zelger B. Retiform hemangioendothelioma: presentation of a case expressing D2-40. J Cutan Pathol. 2009; 36:987–990. PMID: 19674202.
Article
25. Kajo K, Macháleková K, Pauer M. Retiform hemangioendotelioma in a 8-year-old girl--case report. Cesk Patol. 2009; 45:72–74. PMID: 19764161.
26. Aydingöz IE, Mansur AT, Celasun B. Correspondence: retiform hemangioendothelioma presenting as a hyperhidrotic tumor. Int J Dermatol. 2010; 49:1076–1077. PMID: 20883275.
27. Choi WK, Lee SH, Oh SA, Kang DH. Retiform hemangioendothelioma on the finger. Arch Plast Surg. 2012; 39:80–82. PMID: 22783501.
Article
28. Findikçioğlu K, Findikçioğlu F, Kutlugün C, Karabağli P. Retiform hemangioendothelioma originated from capillary malformation: a rare case. Turk J Plast Surg. 2012; 20:12–15.
29. Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol. 2013; 30:29–44. PMID: 23327728.
Article
30. Zhang M, Garvis W, Linder T, Fisch U. Update on the infratemporal fossa approaches to nasopharyngeal angiofibroma. Laryngoscope. 1998; 108:1717–1723. PMID: 9818832.
Article
31. Roche PH, Fournier HD, Laccourreye L, Mercier P. Surgical anatomy of the infratemporal fossa using the transmaxillary approach. Surg Radiol Anat. 2001; 23:209–213. PMID: 11694963.
Article
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr